World's Best Scientists 2026 revealed!
Thomas C. Pearson

Thomas C. Pearson

D-Index & Metrics

Immunology

D-Index
82
Citations
23310
World Ranking
1510
National Ranking
760

Overview

Thomas C. Pearson is affiliated with Emory University in the United States. Their research focuses primarily on the field of Medicine, with a concentration on transplantation, infectious diseases, epidemiology, virology, and accounting.

The main topics covered in their work include:

  • Renal Transplantation Outcomes and Treatments
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Cytomegalovirus and herpesvirus research
  • HIV/AIDS drug development and treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV-related health complications and treatments

Their recent publications are as follows:

  • "CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept," 2020, American Journal of Transplantation
  • "National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States," 2021, Clinical Infectious Diseases
  • "Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States," 2021, Clinical Transplantation
  • "Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression," 2023, Transplantation Direct
  • "Tax-compliant transfer pricing of intra-group services: The soft drink case," 2022, Journal of Accounting Education

Thomas C. Pearson collaborates frequently with several co-authors, including:

  • Sander Florman
  • Peter G. Stock
  • Valentina Stosor
  • Christine M. Durand
  • Shikha Mehta

Their work has appeared in various publication venues, with a majority in transplantation-related journals:

  • American Journal of Transplantation
  • Clinical Infectious Diseases
  • Clinical Transplantation
  • Transplantation Direct
  • Journal of Accounting Education

Best Publications

  • Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

    Christian P. Larsen;Eric T. Elwood;Diane Z. Alexander;Shannon C. Ritchie

  • 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.

    Walter W. Shuford;Kerry Klussman;Douglas D. Tritchler;Deryk T. Loo

  • Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

    Christian P. Larsen;Thomas C. Pearson;Andrew B. Adams;Paul Tso

  • Heterologous immunity provides a potent barrier to transplantation tolerance.

    Andrew B. Adams;Matthew A. Williams;Thomas R. Jones;Nozomu Shirasugi

  • Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways.

    Kenneth Cardona;Gregory S Korbutt;Zvonimir Milas;James Lyon

  • Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells.

    C P Larsen;S C Ritchie;R Hendrix;P S Linsley

  • Transplantation tolerance induced by CTLA4-Ig.

    Thomas C. Pearson;Diane Z. Alexander;Kevin J. Winn;Peter S. Linsley

  • CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway

    Christian P. Larsen;Diane Z. Alexander;Diane Hollenbaugh;Eric T. Elwood

  • Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations

    C P Larsen;S C Ritchie;T C Pearson;P S Linsley

  • Asialo GM1+ CD8+ T cells play a critical role in costimulation blockade–resistant allograft rejection

    Joel Trambley;Adam W. Bingaman;Angello Lin;Eric T. Elwood

  • Cutting Edge: Administration of Anti-CD40 Ligand and Donor Bone Marrow Leads to Hemopoietic Chimerism and Donor-Specific Tolerance Without Cytoreductive Conditioning

    Megan M. Durham;Adam W. Bingaman;Andrew B. Adams;Jongwon Ha

  • IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.

    Bogumila T. Konieczny;Zhenhua Dai;Eric T. Elwood;Sohail Saleem

  • 4-1BB Ligand, a Member of the TNF Family, Is Important for the Generation of Antiviral CD8 T Cell Responses

    Joyce T. Tan;Jason K. Whitmire;Rafi Ahmed;Thomas C. Pearson

  • Heterologous immunity: an overlooked barrier to tolerance.

    Andrew B. Adams;Thomas C. Pearson;Christian P. Larsen

  • Transplanting the highly sensitized patient : The emory algorithm

    R. A. Bray;J. D. L. Nolen;C. Larsen;T. Pearson

  • Development of a Chimeric Anti-CD40 Monoclonal Antibody That Synergizes with LEA29Y to Prolong Islet Allograft Survival

    Andrew B. Adams;Nozomu Shirasugi;Thomas R. Jones;Megan M. Durham

  • The CD40 pathway in allograft rejection, acceptance, and tolerance

    Christian P Larsen;Thomas C Pearson

  • Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory

    M. Suresh;Jason K. Whitmire;Laurie E. Harrington;Christian P. Larsen

  • Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression.

    Andrew B. Adams;Megan M. Durham;Leslie Kean;Nozomu Shirasugi

  • Anti-CD40 therapy extends renal allograft survival in rhesus macaques.

    Thomas C. Pearson;Joel Trambley;Kris Odom;Daniel C. Anderson

  • Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection

    Vaiva Vezys;David Masopust;Christopher C. Kemball;Daniel L. Barber

Frequent Co-Authors

Christian P. Larsen
Christian P. Larsen Emory University
Allan D. Kirk
Allan D. Kirk Duke University
Rafi Ahmed
Rafi Ahmed Emory University
Peter S. Linsley
Peter S. Linsley Benaroya Research Institute
Mandy L. Ford
Mandy L. Ford Emory University
Diane Hollenbaugh
Diane Hollenbaugh Bonum Therapeutics
Alejandro Aruffo
Alejandro Aruffo Syngenta (United States)
Howard M. Gebel
Howard M. Gebel Emory University
Jason K. Whitmire
Jason K. Whitmire University of North Carolina at Chapel Hill
Fadi G. Lakkis
Fadi G. Lakkis University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can broaden career opportunities in healthcare and research. Many choose to begin with foundational nursing programs, which provide essential clinical knowledge and patient care skills. If you are looking for flexible options, consider programs like the easiest accelerated nursing programs to get into. These programs offer a fast track into nursing careers while accommodating busy schedules.

Entry-level nursing can also be pursued through easy LPN programs to get into, which serve as a stepping stone to more advanced roles. From there, advancing to specialized roles such as nurse practitioners is a common pathway, supported by accessible options like the easiest NP programs to get into.

For those focusing on mental health within immunological contexts or chronic diseases, online psychiatric mental health nurse practitioner programs offer targeted training. Programs with strong clinical components, such as the best online psychiatric mental health nurse practitioner programs, ensure graduates are well-prepared for clinical practice.

Choosing the right related degree can significantly impact career pathways in Immunology, blending lab research with patient-centered roles in healthcare.

Best Scientists Citing Thomas C. Pearson

Trending Scientists

Recently Published Articles